STAT’s Adam Feuerstein said viax that, “$RVMD – I had a meeting scheduled with the CEO on Monday morning. The company just cancelled. #JPM26 RevMed is also scheduled to present at the conference on Monday morning. I assume that’s cancelled, too, but I don’t have confirmation.” The Fly notes that After AbbVie (ABBV) denied it is in talks to acquire Revolution Medicines (RVMD), Financial Times reported on Thursday that Merck (MRK) is in talks to buy the cancer drug maker.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on RVMD:
- Video: Trump boosts Intel, Meta charges up nuclear power stocks
- Revolution Medicines price target raised to $147 from $80 at Wedbush
- M&A News: Revolution Medicines (RVMD) Stock Rallies on News of Potential Acquisition by Merck
- Top 5 Trending Stocks by Unusual Trading Volume, 1/9/26
- Revolution Medicines trading resumes